Dr. Lal PathLabs has received shareholder approval to increase its authorized share capital from INR 1,07,96,00,000 to INR 2,00,00,00,000. This decision, made via postal ballot on December 7, 2025, allows the company to enhance its financial flexibility. The alteration to the Memorandum of Association (MOA) reflects this change, dividing the capital into 20,00,00,000 equity shares.
Share Capital Expansion Approved
Dr. Lal PathLabs’ shareholders have approved an increase to the company’s authorized share capital. The approval was secured on December 7, 2025, through a postal ballot.
Revised Capital Structure
The company’s authorized share capital will increase from INR 1,07,96,00,000 (Rupees One Hundred Seven Crore Ninety Six Lakh Only) to INR 2,00,00,00,000 (Rupees Two Hundred Crore Only).
Amended MOA Details
Following the approval, the Memorandum of Association (MOA) has been amended to reflect the new capital structure. The share capital is now divided into 20,00,00,000 (Twenty Crore) Equity Shares with a face value of INR 10 each.
Source: BSE
